Flexion Therapeutics (FLXN) Misses Q1 EPS by 17c

Flexion Therapeutics (NASDAQ: FLXN) reported Q1 EPS of ($0.78), $0.17 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on Flexion Therapeutics (FLXN) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Seven Hills Realty Trust (SEVN) Reiterated at Market Outperform by Citizens Post Q2 Results
• Citi raises Atlassian price target to $225, maintains Buy rating